BSX bostonscientific.com: Multiplikator Forward P/S
Mass procurement of innovative catheters and stents by global clinics is driving the expansion of Boston Scientific (BSX). The expected price-to-sales ratio listed on GURU.Markets confirms the impact of high demand for high-margin neuromodulation systems, with the metric holding around 2.40. The rise in share prices is based on FDA approvals and the expansion of its international presence, which strengthens the fundamental resilience of the business.
Rincian metrik lan analitis perusahaan Boston Scientific Corporation Inc. (BSX)
- rega saiki lan proyeksi nilai saham:
- data kapitalisasi saham perusahaan:
- statistik nilai buku emiten:
- indikator total utang lan likuiditas perusahaan:
Total Utang marang Modal Boston Scientific|BSX - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Boston Scientific|BSX - Utang perusahaan|Utang marang nilai buku Boston Scientific Corporation Inc.|BSX - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Boston Scientific|Likuiditas cepet bostonscientific.com
- rincian asil keuangan lan kelipatan valuasi:
BSX - Bathi resik taunan|Bathi mangsa ngarep Boston Scientific|BSX - Pangali P/E|Pangali Forward P/E Boston Scientific Inc|BSX - Kapitalisasi marang bathi resik kanthi nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Boston Scientific Corporation Inc.|BSX - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Boston Scientific|BSX - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan bostonscientific.com|BSX - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Boston Scientific
- indikator volume dodolan lan pendapatan:
Ringkesan analitik perusahaan:Boston Scientific Corporation (BSX)
To assess the credit quality of Boston Scientific (BSX), the analyst compares market capitalization with expected sales volumes. Business resilience is driven by demand for cardiovascular surgeries and regulatory approval of new medical devices. By analyzing the projected P/S dynamics, the investor determines the risk of asset overvaluation: an inflated ratio leaves quotes vulnerable to any revenue misses, whereas low values reduce the probability of a collapse.
Pesaing wigati
Multiplikator Forward P/S EW (Edwards Lifesciences Corporation)|ResMed Inc (RMD) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|OmniPod - Multiplikator Forward P/S|ZBH (Zimmer Biomet Holdings) - Kapitalisasi marang prakiraan pendapatan|COO: Multiplikator Forward P/S|ALGN - Rasio kapitalisasi marang dodolan sing dikarepake|GMED (Globus Medical) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan TransMedics Group Inc (TMDX)|Multiplikator Forward P/S ATEC|Multiplikator Forward P/S Artivion Corp (AORT)|Rasio rega marang prakiraan pendapatan Enovis Corporation ENOV|integralife.com - Rasio rega marang prakiraan pendapatan|ESTA: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan BBNX (Beta Bionics, Inc.)|IRMD: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Embecta Health (EMBC)|Rasio rega marang prakiraan pendapatan Tandem Diabetes Care|AXGN - Prakiraan rega marang pendapatan|Multiplikator forward rega marang pendapatan SIBN (SI-BONE)|Multiplikator Forward P/S Orthofix Medical (OFIX)|Multiplikator Forward P/S BVS (Bioventus Corp)|Rasio kapitalisasi marang dodolan sing dikarepake OrthoPediatrics Corp (KIDS)|TMCI - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan SRTA|Carlsmed (CARL) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan RxSight Inc|CLPT (ClearPoint Neuro Inc.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Stereotaxis Corporation STXS|Rasio rega marang prakiraan pendapatan Neuronetics, Inc. (STIM)|sightsciences.com - Kapitalisasi marang prakiraan pendapatan|Orchestra BioMed, Inc. - Multiplikator forward rega marang pendapatan|Rasio rega marang pendapatan sing dikarepake ANIK (Anika Therapeutics Inc.)|InspireMD Corp - Multiplikator Forward P/S|ZJYL: Rasio rega marang prakiraan pendapatan|vivani.com (VANI) - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Xtant Medical (XTNT)|Rasio rega marang prakiraan pendapatan NeuroOne Medical Technologies Corporation|Modular Med (MODD) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan MYO (Myomo, Inc)|Rasio rega marang pendapatan sing dikarepake COCH|Rasio rega marang prakiraan pendapatan Vivos Therapeutics VVOS|envveno.com (NVNO) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|SINT - Rasio rega marang prakiraan pendapatan|TNON (Tenon Medical Inc.) - Kapitalisasi marang prakiraan pendapatan|LFWD (ReWalk Robotics Ltd) - Multiplikator forward rega marang pendapatan|Autonomix Medical - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan INVO Fertility Inc|bonebiologics.com (BBLG) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S AXNX|Multiplikator forward rega marang pendapatan BIOLASE Inc. BIOL|Multiplikator Forward P/S DYNT (Dynatronics)|Rasio kapitalisasi marang dodolan sing dikarepake Paragon 28 Inc. (FNA)|INVO Bio - Multiplikator Forward P/S
